Remedy Robotics Raises $62M for AI Cardiovascular Trial Push
Remedy Robotics raised $62 million to move its AI cardiovascular robot N1 toward a pivotal UC trial and FDA review, but the system remains unavailable for clinical use.
Topic
Topic
Remedy Robotics raised $62 million to move its AI cardiovascular robot N1 toward a pivotal UC trial and FDA review, but the system remains unavailable for clinical use.